Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Myomo Inc.

MYONYSE_AMERICANEQUITYCurrent

Changes in Beneficial Ownership

Filed Oct 15, 2026Accepted Oct 15, 2026, 4:22 PM EDTFiling CIK 1369290Accession 0001193125-26-422913
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-10-13
Issuer
MYOMO, INC.
Issuer CIK
0001369290
Trading symbol
MYO

Reporting owner 1

Name
GUDONIS PAUL R
Reporting owner CIK
0001015994
Relationship
Director · Officer
Officer title
Chief Executive Officer
Address
C/O MYOMO, INC., 45 BLUE SKY DR., SUITE 101, BURLINGTON, MA, 01803

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-10-13A · Form 471,250[F1]A01,514,292D
Table key
A · Form 4
Acquisition by grant, award or otherwise under Rule 16b-3(d)
A
Acquired
D
Direct

Footnotes

F1
Represents a grant of Restricted Stock Units ("RSU's") under the Company's 2018 Stock Option and Incentive Plan. The RSU's vest in three equal annual installments beginning on June 9, 2027.↩ 1

Signature 1

Signed
/s/ David A. Henry, Attorney-in-Fact
Date
2026-10-15

Company context

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.

Current securities

Recent company filings

  1. 4 filingOct 15, 2026
  2. 4 filingOct 13, 2026
  3. 4 filingOct 13, 2026
  4. 144 filingOct 13, 2026
  5. S-8 filingOct 13, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.